🇺🇸 Twice-daily combination Darunavir and ritonavir in United States

Twice-daily combination Darunavir and ritonavir (Twice-daily combination Darunavir and ritonavir) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Twice-daily combination Darunavir and ritonavir in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Twice-daily combination Darunavir and ritonavir approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Twice-daily combination Darunavir and ritonavir in United States?

Ruth M. Rothstein CORE Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.